HaemoneticsHAE 
$75.61-1.22%24h
-1.22%24h
Global rank3354
Market cap$3.84B
Change 7d1.33%
YTD Performance-11.07%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Haemonetics (HAE)
As of November 2024, Haemonetics has a market cap of $3.84B. This makes Haemonetics the world's 3354th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Haemonetics from 1991 to 2024
-
Value:-
Market cap history of Haemonetics from 1991 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $3.63B | -16.41% |
| 2023 | $4.34B | 8.72% |
| 2022 | $3.99B | 48.28% |
| 2021 | $2.69B | -55.33% |
| 2020 | $6.03B | 3.35% |
| 2019 | $5.83B | 14.84% |
| 2018 | $5.08B | 72.26% |
| 2017 | $2.95B | 44.48% |
| 2016 | $2.04B | 24.69% |
| 2015 | $1.64B | -13.84% |
| 2014 | $1.90B | -11.18% |
| 2013 | $2.14B | 3.16% |
| 2012 | $2.07B | 33.42% |
| 2011 | $1.55B | -3.10% |
| 2010 | $1.60B | 14.56% |
| 2009 | $1.40B | -2.39% |
| 2008 | $1.43B | -10.35% |
| 2007 | $1.60B | 39.98% |
| 2006 | $1.14B | -7.86% |
| 2005 | $1.24B | 34.94% |
| 2004 | $918.69M | 51.57% |
| 2003 | $606.12M | 11.32% |
| 2002 | $544.47M | -36.73% |
| 2001 | $860.59M | 9.86% |
| 2000 | $783.34M | 29.66% |
| 1999 | $604.15M | 4.67% |
| 1998 | $577.20M | 62.50% |
| 1997 | $355.20M | -25.83% |
| 1996 | $478.88M | 6.34% |
| 1995 | $450.34M | 2.90% |
| 1994 | $437.65M | -37.84% |
| 1993 | $704.05M | 5.97% |
| 1992 | $664.41M | 38.28% |
| 1991 | $480.47M | - |
HAE Market Cap Today is $3.84B -1.22% - 20 Nov 2024
View largest stocks by market cap 
